- Home
- CZFS vs AVIR Comparison
CZFS vs AVIR Comparison
Compare CZFS & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZFS | AVIR |
|---|---|---|
| Founded | 1984 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.7M | 318.0M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CZFS | AVIR |
|---|---|---|
| Price | $59.81 | $5.88 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 6.5K | ★ 564.6K |
| Earning Date | 04-30-2026 | 06-01-2026 |
| Dividend Yield | ★ 3.38% | N/A |
| EPS Growth | ★ 30.26 | 3.00 |
| EPS | ★ 7.62 | N/A |
| Revenue | $9,881,000.00 | ★ $351,367,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.64 | N/A |
| P/E Ratio | $7.77 | ★ N/A |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $49.99 | $2.46 |
| 52 Week High | $69.30 | $6.45 |
Technical Indicators
Market Signals| Indicator | CZFS | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 38.03 | 68.79 |
| Support Level | $58.25 | $3.33 |
| Resistance Level | $62.89 | $6.45 |
| Average True Range (ATR) | 1.81 | 0.33 |
| MACD | -0.25 | 0.03 |
| Stochastic Oscillator | 15.95 | 71.69 |
Price Performance
Historical ComparisonAbout CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).